Skip to main content
Premium Trial:

Request an Annual Quote

VBI Buys 454 GS-FLX Sequencer; Will Enable Institute to 'Tackle Whole Genomes'

NEW YORK (GenomeWeb News) — The Virginia Bioinformatics Institute at Virginia Tech has installed a 454 GS-FLX sequencer at its core lab, the Institute said today.
VBI said installing the 454 sequencer will enable its researchers to sequence 100 megabases in 7 hours, and will be able to achieve lengths of as many as 200 base pairs.
Core lab manager Clive Evans said the GS-FLX will help the institute offer the ability to “tackle whole genomes.”
VBI, located in Blacksburg, Va., focuses on what it calls the “’disease triangle” of host-pathogen-environment interactions in plants, humans, and other animals.”
The core lab provides “various high-throughput technologies” and analysis platforms for DNA sequencing and genotyping, gene expression analysis, and proteomics, VBI said.
Otto Folkerts, associate director of technology development at VBI, said, the institute also is excited about new applications that will be coming along for the sequencer, including “sequencing for transcriptomes, clinical samples, paired-end amplicon sequencing and other cutting edge uses” for the sequencer and its related services. Folkerts said these upcoming applications “dovetail well with our current platforms.”

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.